Search research articles
Contact Us
Filters
Showing results (281-290 of 299) with videos related to
Page
of 30
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 29, 2026
Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approach
Lina Aguilera Munoz, Lucie Laurent, Sandra Salmeron, et al.
Nature Medicine
|
September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis
Coralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Annals of Surgery
|
July 20, 2022
Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network: A Multicentric Retrospective Study
Capucine Bres, Thibault Voron, Leonor Benhaim, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Giovanni Fucà, Romain Cohen, Sara Lonardi, et al.
Journal of Medical Genetics
|
August 29, 2022
First estimates of diffuse gastric cancer risks for carriers of <i>CTNNA1</i> germline pathogenic variants
Marie Coudert, Youenn Drouet, Hélène Delhomelle, et al.
Gastroenterology
|
November 22, 2017
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Renato M Lupinacci, Anastasia Goloudina, Olivier Buhard, et al.
Journal of Medical Genetics
|
February 3, 2016
HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer
Olivier Buhard, Anaïs Lagrange, Agathe Guilloux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2023
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
T Ratovomanana, R Nicolle, R Cohen, et al.
Gastroenterology
|
February 12, 2014
Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy
Ada Collura, Anaïs Lagrange, Magali Svrcek, et al.
Cancer Cell
|
June 11, 2026
Spatial biomarker discovery via interpretable semantic learning in histopathology
Junhao Liang, Xiaofeng Jiang, Nic Gabriel Reitsam, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 299) with videos related to
Sort By:
Page
of 30
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 29, 2026
Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approach
Lina Aguilera Munoz, Lucie Laurent, Sandra Salmeron, et al.
Nature Medicine
|
September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis
Coralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Annals of Surgery
|
July 20, 2022
Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network: A Multicentric Retrospective Study
Capucine Bres, Thibault Voron, Leonor Benhaim, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
Giovanni Fucà, Romain Cohen, Sara Lonardi, et al.
Journal of Medical Genetics
|
August 29, 2022
First estimates of diffuse gastric cancer risks for carriers of <i>CTNNA1</i> germline pathogenic variants
Marie Coudert, Youenn Drouet, Hélène Delhomelle, et al.
Gastroenterology
|
November 22, 2017
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Renato M Lupinacci, Anastasia Goloudina, Olivier Buhard, et al.
Journal of Medical Genetics
|
February 3, 2016
HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer
Olivier Buhard, Anaïs Lagrange, Agathe Guilloux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2023
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
T Ratovomanana, R Nicolle, R Cohen, et al.
Gastroenterology
|
February 12, 2014
Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy
Ada Collura, Anaïs Lagrange, Magali Svrcek, et al.
Cancer Cell
|
June 11, 2026
Spatial biomarker discovery via interpretable semantic learning in histopathology
Junhao Liang, Xiaofeng Jiang, Nic Gabriel Reitsam, et al.
Page
of 30